CCR6 and neoplasm: A previous study showed that Treg cells from both the tumor microenvironment and dLNs in HNSCC patients exhibited a CCR6+ effector Treg cell phenotype, and CCR6+ Treg cells expressed a higher level of FOXP3 than CCR6− Treg cells, which indicated a stronger suppressive function.32